Nanovibronix, Inc. (NASDAQ:FEED) Sees Significant Decline in Short Interest

Nanovibronix, Inc. (NASDAQ:FEED) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 74,962 shares, a decrease of 53.6% from the July 15th total of 161,665 shares. Currently, 1.4% of the company’s stock are short sold. Based on an average daily volume of 202,909 shares, the days-to-cover ratio is presently 0.4 days.

Insider Buying and Selling

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $0.69, for a total transaction of $144,900.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 12.20% of the company’s stock.

Nanovibronix Stock Performance

Shares of FEED traded up $0.06 during mid-day trading on Friday, hitting $0.44. 857,848 shares of the company traded hands, compared to its average volume of 1,576,550. The stock has a market cap of $2.66 million, a price-to-earnings ratio of -0.05 and a beta of 1.38. Nanovibronix has a 1 year low of $0.29 and a 1 year high of $17.40. The stock has a 50-day moving average price of $0.52 and a two-hundred day moving average price of $1.35.

Nanovibronix (NASDAQ:FEED) last posted its earnings results on Monday, May 18th. The company reported ($6.88) earnings per share for the quarter. The firm had revenue of $0.65 million during the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Nanovibronix in a research report on Tuesday, July 21st. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non?invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low?intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound?care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound?care clinics, long?term care facilities and patients requiring home?based therapies.